Antibiotics/infections Flashcards
(41 cards)
1) Define MBC vs MIC
2) what’s the importance of MBC/MIC ratio? At what ratio is an Abx considered bacteriostatic Vs bactericidal?
1)MIC (minimum inhibitory concentration) - The minimum concentration of a certain antibiotic (ug/ML) to inhibit visible bacterial growth after incubation for 24 hours
MBC (minimum bacterial concentration) - The minimal concentration of a certain antibiotic (ug/ML) necessary to kill 99.9% of bacteria after incubation for 24 hours
2) The MBC/MIC ratio determines whether antibiotic is bactericidal or bacteriostatic. This ratio is a relative sense factors such as penetration/wound factors (presence of necrotic tissue, clots, fluid, foreign body) also affect antibiotic effect. A factor of 4 or less indicate that the antibiotic is bactericidal.
Antibiotics are typically classified according to their mechanism of action. Those are…(6)
1)Destruction or alteration of the bacterial cell wall;
2) inhibition of protein synthesis. 
3) inhibition of DNA synthesis
4) inhibition of RNA synthesis
5) Mycolic acid synthesis inhibition
6) Folic Acid Synthesis inhibition
Mechanism of action and five examples of beta-lactam ring antibiotics
Disruption of the bacterial cell wall, leading to increased permeability and lysis. Time dependent, bactericidal, eliminated via kidneys
Penicillins, cephalosporins, carbapenens, monobactams, vancomycin, bacitracin; anti-fungal drugs nystatin and polymyxin B
Aminopenicillins - two examples, spectrum,  mechanism of bacterial resistance, compounds added to decrease resistance
Amoxicillin, ampicillin; most gram-positive aerobes, certain gram-positive and gram-negative anaerobes; resistance through penicillinases which prevent antibiotic adherence to the cell wall; Clavulanic acid and sulfabactam added for anti-penicillinase effect
Cephalosporins - mechanism of action, spectrum per generation
Disruption of the bacterial cell wall leading to altered permeability and cell lysis; more effective than penicillins against Gram-negatives (Enterobacteriaceae); resistance also through penicillinases;
First generation (cefazolin, cephalexin) - effective against most gram-positive and some gram-negative organisms, but not anaerobes
Second generation (cefoxitin, cefovecin)
greater activity against gram-negative bacteria and anaerobes but no additional efficacy against gram-positive organisms
Third generation (cefotaxime, cefpodoxime) - highly effective against more than 90% of gram-negative bacteria, but they often are less active against gram-positive organisms than first-generation cephalosporins * this is not consistent among third generation cephalosporins* - cefpodoxime, for instant, offers good activity against most streptococci and staphylococci and Enterobacteriaceae
Carbapenems - class, mechanism of action, spectrum, known resistance
Beta-lactam ring antibiotic; disruption of the bacterial cell wall; broad gram-negative and gram-positive spectra and are highly resistant to most β-lactamases ; excessive use has already produced resistant bacteria, especially Enterobacteriaceae (i.e., Klebsiella and E. coli). 
Antibiotics that inhibit bacterial proteins synthesis - 4 examples, mechanism of action;
Chloramphenicol, tetracycline, erythromycin, and clindamycin bind to bacterial ribosomes, causing reversible inhibition of protein synthesis
Chloramphenicol - mechanism of action, spectrum, excretion, potential adverse effects
Mechanism of action - Inhibition of bacterial proteins synthesis; considered bacteriostatic but achieves high enough tissue concentration to be bactericidal; highly lipophilic, penetrates eye and CNS;
Spectrum - most anaerobic and aerobic bacteria, as well as Ehrlichia spp. and Rickettsia spp., but poor activity against Pseudomonas spp;
Excretion - hepatic metabolism and urine excretion
Potential adverse effect - mild, transient anemia (severe in people). Suppresses cytochrome P450, affecting hepatic metabolism of certain drugs
Tetracyclines - mechanism of action, preferred drug choice, spectrum of activity; metabolism; precautions/adverse effects
Mechanism of action - inhibits bacterial protein synthesis; well distributed in most tissues but does not penetrate CNS
Preferred drug choice - doxycycline (Fewer side effects, last resistance)
Specrum - effective against many gram-positive and gram-negative bacteria, including Chlamydia spp., rickettsia, spirochetes, Mycoplasma spp., bacterial L-forms, and some protozoa. They are usually ineffective against staphylococci, enterococci, Pseudomonas spp., and Enterobacteriaceae; typically used against tickborne diseases and for prostatic infections.
Metabolism - intestinal excretion
Precautions/adverse effects - binds to calcium. Should not be administered with milk products. Will bind to dental calcium in young patients leading to staining. potential for hepatic toxicity and esophagitis.
Macrolides - mechanism of action, metabolism, preferred drug choice, spectrum of activity
Mechanism of action - inhibition of bacterial protein synthesis
Metabolism - easily diffuses through tissues and accumulates in phagocytic cells; eliminated in the bile
Preferred drug choice - Azithromycin (active against aerobic bacteria, such as staphylococci and streptococci, and anaerobes. It also has good activity against Mycoplasma spp. and intracellular organisms, such as Bartonella spp., Toxoplasma spp., and atypical mycobacteria).
Clindamycin - mechanism of action, metabolism, spectrum of activity; adverse affect
Mechanism of action - inhibition of bacterial proteins synthesis
Metabolism -  excellent concentrations in the skin and bones, as well as high concentrations in white blood cells. Excreted in the bile
Spectrum of activity - effective against most anaerobic bacteria, plus it is active against many gram-positive pathogens. Effective against toxoplasma and Neospora. Typical indications include intra-abdominal infections, osteomyelitis, discospondylitis, and oral/dental disease. Can be used as part of therapy against Pseudomonas because it inhibits bacterial adherence to epithelial cells, making it more susceptible to other antibiotics.
Adverse effects - can cause esophagitis in cats
Aminoglycosides - mechanism of action, metabolism, preferred drug choices, spectrum of action, adverse effects, common combinations
Mechanism of action: inhibition of bacterial proteins synthesis
Metabolism: Poor oral absorption; concentration dependent (given QD); Limited distribution in the extra cellular and cerebrospinal fluid; good distribution into the pleural fluid, bone, joints, and peritoneal cavity is good
Preferred drug choices: amikacin, gentamicin, neomycin, tobramycin
Adverse effects: nephrotoxicity, particularly if dehydrated, used with potentially nephrotoxic drugs (I.e. NSAID’s) or if patient already has renal disease; neuromuscular blockade and ototoxicity possible but infrequently observed
Spectrum of activity: effective against gram-negative and gram-positive bacteria, including Enterobacteriaceae and pseudomonads, but not anaerobes. Their activity is reduced in necrotic tissue because of free nucleic acid material.
Common combo: combination of a β-lactam and an aminoglycoside is often synergistic, plus it helps prevent bacteria from becoming resistant to these drugs.
Antibiotics that inhibit DNA synthesis - two major classes,
Classes - Fluoroquinolones and potentiated sulfas
Fluoroquinolones: 3 examples;  mechanism of action/metabolism; spectrum; adverse effects
Examples: enrofloxacin; marbofloxacin; orbifloxacin
Mechanism of action/Metabolism: inhibit DNA synthesis, bactericidal, concentration dependent, concentrates in phagocytic cells, primarily excreted to the kidneys.
Spectrum of Activity: principally gram-negative spectrum but is also effective against Rickettsia rickettsii, Mycobacteria, and possibly L-form bacteria. Enrofloxacin is poorly effective against most gram-positive cocci and anaerobic bacteria except for newer fluoroquinolones (e.g., pradofloxacin) have enhanced anaerobic activity.
Marbofloxacin - very good activity against all major pathogens associated with surgical infections; single IV injection of 2 to 4 mg/kg maintains plasma concentrations above the MIC for Enterobacteriaceae and staphylococci for 12 to 24 hours.
Ciprofloxacin - poor bioavailability in the dog (40%) in comparison to people (80%), so frequently underdosed
Adverse Effects: blindness in cats, CNS effects, cartilage lesions in rapidly growing large breed dogs, and vomiting. Rapid IV injection of undiluted enrofloxacin can be fatal.
Trimethoprim-Sulfonamide; mechanism of action; metabolism; common uses; spectrum; adverse effects
Mechanism of action: inhibits bacterial Folate synthesis; Time-dependent bactericidal - difficult for bacteria to develop resistance. Tissue concentration depends on the type of sulfonamide
Metabolism: hepatic metabolism, Renal excretion.
Common uses: osteomyelitis, prostatitis, pneumonia, tracheobronchitis, pyoderma, and UTI.
Spectrum: broad spectrum of activity against gram-positive and gram-negative bacteria, as well as Nocardia spp. and anaerobic bacteria. They are usually not effective against pseudomonads
Adverse effects: keratoconjunctivitis sicca, thrombocytopenia, anemia, neutropenia, bone marrow suppression, fever, vomiting, hypersensitivity (i.e., vasculitis or arthritis), and hepatic disease. Some breeds (e.g., miniature Schnauzers, Samoyeds, Doberman pinschers) and some families of dogs seem more likely to suffer side effects, probably because of altered hepatic metabolism.
Metronidazole - spectrum; penetration
Spectrum - effective against most anaerobes
Penetration - good in most body tissues
Adverse effects - CNS toxicity in higher doses

Factors that contribute to antibiotic therapy failure
Factors contributing to therapeutic failure include inappropriate dose, frequency, or route of administration; inadequate duration of treatment; inappropriate antibiotic selection; presence of foreign material (i.e., foreign body or implant); inability of sufficient antibiotic to reach the target tissue (e.g., cross the blood-brain barrier); bacterial resistance (see later discussion); depressed host immunity (e.g., concurrent debilitating illness, immunosuppressive drug therapy); pharmacokinetics of the drug; drug reactions; antibiotic antagonism; and incorrect diagnoses (i.e., viral diseases or foreign bodies misdiagnosed as primary bacterial infections)
What are the two mechanisms of bacterial resistance to antibiotics
There are two main ways that bacteria develop resistance; they can alter the site that the antibiotic targets (i.e., receptors in/on the bacteria), or they can alter the concentration of the antibiotic in the bacteria. Intracellular concentrations may be altered by enzymatic destruction of the antibiotic (e.g., β-lactamases), decreasing bacterial permeability to the antibiotic (e.g., altering porin size such that antibiotics can no longer access intracellular targets), or developing efflux proteins (i.e., these are closely associated with porins, and they pump specific chemicals out of the bacteria).
SSI categories according to the CDC; criteria
Superficial incisional - within 30 days of Sx, only skin/SQ +
- purulent exudate with or without pos. culture OR
- pos. culture OR
- signs of infection (unless culture negative)
Deep incisional - within 30 days of Sx w/o implants or 1 year with implants AND involves deep soft tissue (muscle/fascia) +
- Purulent exudate from deep incision but not from organ/space OR
- Deep incision dehisces or is opened by surgeon with fever or localized pain (unless culture negative)
- Abscess is identified
- Diagnosis of deep incision infection made by surgeon or clinician
Organ/space - within 30 days of Sx w/o implants or 1 year with implants AND involves organ or cavity other than the incision manipulated during the operation +
- purulent exudate from a drain placed into organ/cavity
- positive bacterial culture of fluid or tissue
- abscess identified
- Diagnosis of deep incision infection made by surgeon or clinician
Incidence of SSI in veterinary patients, divided by superficial, deep and organ/space; most common pathogen; time frame for diagnosis
The incidence of SSI in this study was 3% overall with 42% classified as superficial, 50% classified as deep, and 8% as organ/space. The most prominent bacterial species cultured in this study was methicillin-resistant Staphylococcus pseudintermedius (MRSP) at 47%. The majority of SSIs are recognized within 30 days of surgery
Wound Classification System - Clean wound, examples
Nontraumatic, noninflamed operative wounds in which the respiratory, gastrointestinal, genitourinary, and oropharyngeal tracts are not entered
Elective celiotomy (for spay, for example), TPLO, THR, PDA
Wound Classification System - Clean-contaminated wound, examples
Operative wounds in which the respiratory, gastrointestinal, or genitourinary tract is entered under controlled conditions without unusual contamination; an otherwise clean wound in which a drain is placed
Enterotomy, small intestinal resection/anastomosis, bronchoscopy
* includes perforation of surgical glove
Wound Classification System - Contaminated wound, examples
Open, fresh, accidental wounds; procedures in which gastrointestinal contents or infected urine is spilled or a major break in aseptic technique occurs
Cystotomy with spillage of urine; cholecystectomy with spillage of bile
Wound Classification System - dirty, examples
Old traumatic wounds with purulent discharge, devitalized tissue, or foreign bodies; procedures in which a viscus is perforated or fecal contamination occurs
Abscess, peritonitis, TECA